NSS1
Joint IOF and CABS Symposium - Cancer and Bone
Chairpersons: P. Hadji, R. Coleman
‣ Cancer treatment induced osteoporosis - really important? - P. Hadji
‣ Influence of adj. bisphosphonates and denosumab on breast cancer outcome. - R. Coleman
‣ Surgical treatment of bone metastasis – Update 2021 - A.A. Kurth


NSS2
The Asia Pacific Consortium on Osteoporosis (APCO) NSS Paving the Way Forward for Harmonization of Osteoporosis Guidelines - the Pan Asia and Oceania FRAMEWORK of the Asia Pacific Consortium on Osteoporosis (APCO)
Chairpersons: Cyrus Cooper, Philippe Halbout
‣ The Asia Pacific Consortium on Osteoporosis – A brief introduction - Manju Chandran
‣ 5IQ: A novel analysis of extant guidelines - Paul Mitchell
‣ The Delphi Process: Developing consensus amongst experts from 19 countries and regions - Manju Chandran
‣ Embedding the Framework in the Asia Pacific - Greg Lyubomirsky and Ms Thalia Georgiou
‣ Conclusion


NSS3
Breast Cancer and Osteoporosis
Chairperson: Yannis Dionyssiotis
‣ Breast cancer and osteoporosis - Lambros Athanassiou
‣ Estrogen receptor antagonists and osteoporosis - Yannis Dionyssiotis
‣ Pathophysiology of osteoporosis in the context of estrogen receptor antagonist treatment - Panagiotis Athanassiou
‣ Management of osteoporosis in breast cancer patients - Ifigenia Kostoglou-Athanassiou


NSS4
Exosomes to diagnose and treat musculoskeletal diseases: An update
Chairperson: Gustavo Duque
‣ Extracellular vesicles in musculoskeletal diseases - Mark W. Hamrick
‣ The role of extracellular vesicles in the pathophysiology and treatment of osteosarcopenia - Gustavo Duque
‣ Therapeutic applications of MSC derived extracellular vesicles in osteoarthritis - Susanne Grässel


NSS5
SARC-F for sarcopenia: high potential for new applications
Chairperson: John Morley
‣ The comparison of SARC-F with other screening tools for sarcopenia. - Karolina Piotrowicz
‣ SARC-F Questionnaire Detects Frailty in Older Adults - Serdar Ozkok
‣ Ability of SARC-F to Find Probable Sarcopenia Cases in Older Adults: application of alternative cut-offs - Gülistan Bahat


NSS6
Crystals at the crossroad between inflammation and degeneration
Chairperson: Razvan Adrian Ionescu
‣ Check your past, know your future - Claudiu Avram
‣ Getting well or getting hell - Razvan Ionescu
‣ The chicken or the egg: the causality dilemma - Mihai Bojinca
‣ Look into the crystal bowl - Florentin Ananu Vreju


NSS7
Occupational musculoskeletal hazards among health professionals
Chairperson: Yesim Gökçe-Kutsal
‣ Are health professionals vulnerable to work-related musculoskeletal disorders? - Yesim Gökçe-Kutsal
‣ Neck and upper extremity disorders among health professionals - Yesim Kirazli
‣ Occupational back and lower extremity problems in health personnel - Ayse A. Küçükdeveci


NSS8
Osteoporosis in 2020+: Flattening The Curve of Fragility Fractures
Chairperson: Bruno Muzzi Camargos
‣ Introduction - Bruno Muzzi Camargos
‣ Do You Believe in Tests ? - John Carey
‣ To Mask or Not To Mask ? - Jorge Morales-Torres
‣ How Awareness Could Change a Common Fate - Bruno Muzzi Camargos
‣ Wrap-up/Discussion


NSS10
Fracture Liaison Services (FLS) in Latin America: From Where and Where To
Chairperson: Bruno Muzzi Camargos
‣ Introduction - Overview of FLS in Latin America - Bruno Muzzi Camargos
‣ Situation of the FLS in Mexico: barriers and strengths - Andrea Olascoaga Gómez de León
‣ How fracture liaison services (FLS) impacted post-fracture outcomes in Colombia? - Adriana Medina Orjuela
‣ FLS in public and private systems in Brazil: two worlds and a single outcome. - Bernardo Stolnick
‣ Conclusion - Bruno Muzzi Camargos


NSS11
Osteoporosis in the context of autoimmune rheumatic diseases
Chairperson: Panagiotis Athanassiou
‣ Autoimmune rheumatic diseases and osteoporosis - Panagiotis Athanassiou
‣ Autoimmunity and osteoporosis - Ifigenia Kostoglou-Athanassiou
‣ Biologic agents in autoimmune rheumatic diseases and bone health - Lambros Athanassiou
‣ Management of osteoporosis in the context of autoimmune rheumatic diseases - Yannis Dionyssiotis


NSS12
Presentation of the book “Osteoporois: mitos y realidades“ (“Osteoporosis: myths and realities“)
Chairperson: David Vasquez-Awad
‣ Opening - David Vasquez-Awad
‣ "Osteoporosis: myths and realities" – the book - Jorge Felipe Ramirez
‣ Osteoporosis: an economic perspective - Diego Rosselli
‣ Osteoporosis, epidemic of the 21st century - David Vasquez-Awad
‣ Conclusions and closure - Jorge Felipe Ramirez, Diego Rosselli, David Vasquez-Awad


NSS13
The State of the Art in Hypophosphatasia (HPP) Diagnosis in Adults and Children
Chairperson: Serge Ferrari
‣ Current State in Diagnosis of HPP - Aliya Khan
‣ Diagnostic Criteria for Children and Adolescents with - Eric Rush
‣ Diagnostic Criteria for Adults with HPP - Maria Luisa Brandi


NSS14
Improving the Communication of Fracture risk
Chairperson: Mickael Hiligsmann
‣ Welcome and introduction - Stuart Silverman
‣ What can we learn from the literature? - Charlotte Beaudart
‣ Insights from interviews with patients at risk for fractures (the RICO study) - Mickael Hiligsmann
‣ - Key points, next steps & conclusion - Stuart Silverman


NSS15
Exercise to prevent deconditioning of older people during the covid-19 pandemic: from clinic to community setting
Chairperson: Mylène Aubertin-Leheudre
‣ Feasibility of implementing physical activity programs in hospitalized positive covid-19 older adults - Yves Rolland
‣ Remote Physical Activity using Web Technology to Prevent Isolation-Related Mobility Loss in Independent older adults: a solution during the COVID-19 pandemic? - Mylène Aubertin-Leheudre
‣ Impacts of COVID-19 restrictions on functional status and mobility among community-dwelling pre-disabled seniors: Virtual Physical Exercises at Home, a solution? - Fanny Buckinx


NSS16
Osteosarcopenia in disabled persons
Chairperson: Christina-Anastasia Rapidi
‣ Osteosarcopenia and neurodisability - Yannis Dionyssiotis
‣ Physical activity in osteoporosis and sarcopenia management and rehabilitation - Mark A. Lissens
‣ Conclusion - Discussion - All


NSS17
Rapid risk assessment and cost-effective methods for Osteoporosis in low resource settings – implication for practice
Chairperson: Fatjona Kamberi
‣ Rapid risk assessment of osteoporosis using cost-effective methods – evidence from a cross sectional study in a South Eastern European country - Fatjona Kamberi
‣ Health beliefs, knowledge and barriers of women in local population regarding Osteoporosis – A cross-sectional study - Enkeleda Sinaj
‣ Awareness for early detection of Osteoporosis what the research in low resource settings suggests – evidence from a review study - Vjollca Ndreu
‣ The role of vitamin D in patients with osteoporosis-review - Jerina Jaho


NSS18
Depression, antidepressive treatment and osteoporosis
‣ Depression and osteoporosis - Ifigenia Kostoglou-Athanassiou
‣ Stress and osteoporosis - Panagiotis Athanassiou
‣ Antidepressive agents and osteoporosis - Lambros Athanassiou
‣ Management of osteoporosis in the context of depression - Yannis Dionyssiotis


NSS19
Interdisciplinary approach to chronic musculoskeletal pain
Chairperson: Olga Kurushina
‣ Interdisciplinary approach to biomechanics in chronic musculoskeletal pain - Alexander Barulin
‣ Psychosomatics and cognitive-behavioral therapy in the treatment of chronic musculoskeletal pain - Olga Kurushina
‣ Kinesiotaping in the correction of myofascial pain - Bogdan Kalinchenko
‣ Non-pharmacological treatment in chronic musculoskeletal pain - Anna Drushlyakova


NSS20
The importance of Mediterranean diet in muscoloskeletal diseases
Chairperson: Stefania Maggi
‣ Mediterranean diet and sarcopenia - Elaine Dennison
‣ Mediterranean diet, osteoporosis and fracture - René Rizzoli
‣ Mediterranean diet in osteoarthritis and other inflammatory rheumatological diseases - Nicola Veronese


NSS21
The effects of vitamin K on bone; beyond coagulation
Chairperson: Bo Abrahamsen
‣ The biology of the active forms of vitamin K. - Dominic Harrington
‣ The effects of vitamin K on bone health - Geeta Hampson


NSS22
Management of glucocorticoid induced osteoporosis
Chairpersons: Osvaldo Daniel Messina, Luis F Vidal Neira
‣ Epidemiology and Pathogenesis - OD Messina
‣ Clinical features and diagnosis - OD Messina
‣ Therapeutic options: Candidates for receiving therapy - H Ratermann
‣ Modern treatment - W Lems


NSS23
Osteoclast activity defining bone strength in health and disease
Chairpersons: Marise Lazaretti Castro, Francisco José de Paula
‣ Switching the osteoclast behavior determines the bone remodeling - Sandra Yasuyo Fukada
‣ Osteoclasts on: bone fragility in the primary hyperparathyroidism - Francisco Bandeira
‣ Osteoclasts off: quality of bone and fracture risk in the hypoparathyroidism - João Lindolfo Cunha Borges
‣ Closing: last considerations


NSS24
Assessing quality of life in sarcopenia: new insights from the SarQoL® questionnaire”
Chairperson: Olivier Bruyère
‣ Welcome, introduction and presentation of the SarQoL® questionnaire - Jean-Yves Reginster
‣ Lecture 1. Clinimetric properties of Patient Reported Outcome Measures (PROMS) – Which methods for which purpose?: - Anton Geerinck
‣ Lecture 2. The SarQoL® questionnaire – Clinimetric properties and novel applications - Charlotte Beaudart
‣ Lecture 3. The Short-Form SarQoL® questionnaire - Development and validation of a Short Form Measure - Anton Geerinck
‣ Key points & Discussion - Olivier Bruyère